Drug treatments for cognitive impairment due to ageing and disease: Current and future strategies
- 1 November 1989
- journal article
- research article
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 4 (6) , 345-353
- https://doi.org/10.1002/gps.930040608
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- Oxpentifylline in dementia: a controlled studyArchives of Gerontology and Geriatrics, 1987
- Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer TypeNew England Journal of Medicine, 1986
- Protection from cerebral ischemia by U-50,488E, a specific kappa opioid analgesic agentLife Sciences, 1985
- Haemorheological pattern in initial mental deterioration: results of a long-term study using piracetam and pentoxifyllineArchives of Gerontology and Geriatrics, 1985
- Effect of centrophenoxine on the antioxidative enzymes in various regions of the aging rat brainExperimental Gerontology, 1983
- Reduction of lipofuscin by centrophenoxine and chlorpromazine in the neurons of rat cerebral hemisphere in primary cultureExperimental Gerontology, 1983
- The effect of acute and chronic centrophenoxine treatment on the synaptic plasticity of old ratsArchives of Gerontology and Geriatrics, 1982
- Neuronal Lipofuscin Accumulation in Ageing and Alzheimer Dementia: A Pathogenic Mechanism?The British Journal of Psychiatry, 1982
- Antianoxic effect of meclofenoxate related to its disposition.CHEMICAL & PHARMACEUTICAL BULLETIN, 1976
- Effect of dimethylaminoethyl p-chlorophenoxyacetate on the life span of male swiss webster albino miceExperimental Gerontology, 1973